BELE INVEST ApS: Financial statements 2014
CVR: 20275499
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
BELE INVEST ApS (CVR 20275499) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -1,386,561 and a net result of DKK -1,579,251 compared with DKK -1,032,949 the year before. Equity in the 2014 report amounted to DKK 222,901. The solvency ratio was 7.6%.
- Gross Profit
- DKK -1,386,561
- Profit/Loss
- DKK -1,579,251
- Equity
- DKK 222,901
- Total Assets
- DKK 2,950,057
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of August 5, 2014, Jørgen Christian Rasmussen is registered as direktion of BELE INVEST ApS.
As of April 1, 2014, Jens Aabye Dam has stepped down as direktion of BELE INVEST ApS.
About BELE INVEST ApS
BELE INVEST ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 1997. The company has been dissolved on 26 July 2017. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named T-CELLIC A/S and TORSANA ONCOLOGY SYSTEMS A/S. The company has 15 employees (2005). In 2015, the company reported a gross profit of DKK 4,781 and a net result of DKK -163,046 compared with DKK -1,579,251 the year before. Equity in the 2015 report amounted to DKK 59,854.